SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-16-001662
Filing Date
2016-11-16
Accepted
2016-11-16 13:19:57
Documents
2
Group Members
ROSALIND ADVISORS, INC.ROSALIND CAPITAL PARTNERS L.P.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G zosano_13g.htm SC 13G 121064
2 EXHIBIT A ex_a.htm EX-99.A 8139
  Complete submission text file 0001019056-16-001662.txt   130919
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Subject) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88596 | Film No.: 162001973
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 BLOOR STREET EAST SUITE 807, SOUTH TOWER TORONTO A6 M4W 3R8
Business Address 27 ADMIRAL RD. TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G